Kazia Therapeutics Ltd SEC filings KZIA
Kazia Therapeutics Ltd has 1,000 filings in SEC EDGAR's recent list, going back to May 1, 2007. Its latest annual report, Form 20-F, was filed on Nov 7, 2025 for the period ended Jun 30, 2025. The most recent current report (Form 6-K) was filed on Sep 22, 2026. The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 20-F | Annual report (foreign issuer) | Nov 7, 2025 | Jun 30, 2025 |
| 20-F | Annual report (foreign issuer) | Nov 15, 2024 | Jun 30, 2024 |
| 20-F | Annual report (foreign issuer) | Oct 26, 2023 | Jun 30, 2023 |
| 20-F | Annual report (foreign issuer) | Oct 17, 2022 | Jun 30, 2022 |
| 20-F | Annual report (foreign issuer) | Oct 7, 2021 | Jun 30, 2021 |
| 20-F | Annual report (foreign issuer) | Oct 22, 2020 | Jun 30, 2020 |
| 20-F | Annual report (foreign issuer) | Oct 21, 2019 | Jun 30, 2019 |
| 20-F | Annual report (foreign issuer) | Oct 24, 2018 | Jun 30, 2018 |
| 20-F/A | Amended annual report (foreign issuer) | Dec 18, 2017 | Jun 30, 2017 |
| 20-F | Annual report (foreign issuer) | Oct 25, 2017 | Jun 30, 2017 |
| 20-F | Annual report (foreign issuer) | Oct 27, 2016 | Jun 30, 2016 |
| 20-F | Annual report (foreign issuer) | Oct 30, 2015 | Jun 30, 2015 |
| 20-F | Annual report (foreign issuer) | Oct 31, 2014 | Jun 30, 2014 |
| 20-F | Annual report (foreign issuer) | Oct 31, 2013 | Jun 30, 2013 |
| 20-F/A | Amended annual report (foreign issuer) | Jul 5, 2013 | Jun 30, 2012 |
| 20-F | Annual report (foreign issuer) | Oct 29, 2012 | Oct 8, 2012 |
| 20-F | Annual report (foreign issuer) | Dec 13, 2011 | Nov 22, 2011 |
| 20-F | Annual report (foreign issuer) | Dec 13, 2010 | Jun 30, 2010 |
| 20-F/A | Amended annual report (foreign issuer) | May 18, 2010 | Nov 26, 2009 |
| 20-F | Annual report (foreign issuer) | Dec 15, 2009 | Nov 26, 2009 |
| 20-F/A | Amended annual report (foreign issuer) | May 5, 2009 | Jun 30, 2008 |
| 20-F/A | Amended annual report (foreign issuer) | Mar 20, 2009 | Jun 30, 2008 |
| 20-F | Annual report (foreign issuer) | Dec 5, 2008 | Jun 30, 2008 |
| 20-F | Annual report (foreign issuer) | Dec 14, 2007 | Jun 30, 2007 |
Showing 24 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- KZIA (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- Australia
- Headquarters
- Sydney Nsw
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1075880
- Former names
- NOVOGEN LTD (until Nov 17, 2017)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.